Test Menu Test Ordering Information Test Requisition Forms
Cancer Test Menu Protean MAPS® Genetic Testing: Risk MAPS™
Cancer Consultations Cancer Test Information Risk MAPS™ Hereditary Testing
Research Services Collaborative Research Opportunities Research Publications
Blog Press Cancer Podcast
About Us The Team Careers Contact
 
 

Limited time investment opportunity for current investors.

 
 
LungEdit.jpg
 

Recent Highlights

  • The launch of Protean MAPS® for CNS & Brain has resulted in over 20 major cancer hospitals signing on with Protean (with more to come) and a 500% increase in clinical case volume

  • Protean has become cash flow positive, and the outlook for the future looks very bright with projected revenue of 6 million within the next 12 months

  • Limited opportunity to invest at current valuation

 

Request More Information

A member of Protean’s team will contact you shortly.

By entering your contact information, you opt-in to receive communications from Protean BioDiagnostics by email, SMS and phone. We will never share or sell your information. You may unsubscribe at any time.